EUVIMEDEUVIMED entdecken
Crossref

The Present Status of LAK Cell plus IL-2 Immunotherapy for Malignant Gliomas(What is the Best Treatment for Malignant Gliomas?)

Seiichi Yoshida, Ryuichi Tanaka, Nobuyuki Takai, Koji Ono, Hiroshi Mori

Japanese Journal of Neurosurgery · 1992

DOI: 10.7887/jcns.1.110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Neurosurgery, 1992. Verfasst von Seiichi Yoshida und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yoshida, S., Tanaka, R., Takai, N., Ono, K., & Mori, H. (1992). The Present Status of LAK Cell plus IL-2 Immunotherapy for Malignant Gliomas(What is the Best Treatment for Malignant Gliomas?). Japanese Journal of Neurosurgery. https://doi.org/10.7887/jcns.1.110

Vancouver

Yoshida S, Tanaka R, Takai N, Ono K, Mori H. The Present Status of LAK Cell plus IL-2 Immunotherapy for Malignant Gliomas(What is the Best Treatment for Malignant Gliomas?). Japanese Journal of Neurosurgery. 1992. doi:10.7887/jcns.1.110

BibTeX
@article{Yoshida1992,
  author = {Yoshida, Seiichi and Tanaka, Ryuichi and Takai, Nobuyuki and Ono, Koji and Mori, Hiroshi},
  title = {The Present Status of LAK Cell plus IL-2 Immunotherapy for Malignant Gliomas(What is the Best Treatment for Malignant Gliomas?)},
  journal = {Japanese Journal of Neurosurgery},
  year = {1992},
  doi = {10.7887/jcns.1.110}
}
Kostenlos starten →